News
Statement from Wells Fargo CEO Charlie Scharf
Wells Fargo CEO Charlie Scharf today issued the following statement regarding President Biden’s announcement of his intent to renominate Jerome Powell as Chair of the Board of Governors of the
![Teleperformance: Upgraded Credit Rating: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMmtqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--962a7d9f0913a6de3def41c1b56a4583ad5632a4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo_-_new.jpg?locale=us)
Teleperformance: Upgraded Credit Rating
Regulatory News:
Teleperformance (Paris:TEP), a leading global group in digitally integrated business services, announced today that its public long-term corporate credit rating has been
![Transgene and NEC Announce Positive Preliminary Data From Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOFo2Rmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--73fe07bc16ac0607e1cc0e1a0b34e650fa94b07d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo_TRANSGENE.jpg?locale=us)
Transgene and NEC Announce Positive Preliminary Data From Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE:
![Société de la Tour Eiffel announces two leases for its new K-Bis building, in the Carré de Soie district, in Greater Lyon](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
Société de la Tour Eiffel announces two leases for its new K-Bis building, in the Carré de Soie district, in Greater Lyon
PRESS RELEASE Paris, November 22, 2021 - 5:45 pm
Société de la Tour Eiffel announces two leases for its new K-Bis building,
in the Carré de Soie district, in Greater Lyon
Société de la Tour
![Raven Industries Awarded Prime Contract for Stratospheric Balloon Systems & Services](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
Raven Industries Awarded Prime Contract for Stratospheric Balloon Systems & Services
Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that Defense Innovation Unit (DIU) has awarded a contract to Aerostar Technical Solutions, Inc. (Raven Aerostar) to provide robust
![Humana Announces Value-Based Agreement with Allina Health in Minnesota: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaXNCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--3d3c39355769d1759c5221ae0bf511106538ecb5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Humana_logo.png?locale=us)
Humana Announces Value-Based Agreement with Allina Health in Minnesota
Humana Inc. (NYSE: HUM), a leading health and well-being company, and Allina Health are expanding their existing agreement to focus on value-based care for Humana’s Medicare Advantage members in
![Best Pick For Corona Woes](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Best Pick For Corona Woes
S&P 500 stumbled as value plunged – corona fears are back as Austria lockdown might very well be followed soon by Germany. The mood on the continent is souring, and coupled with accelerating
![Chewy Matches Customer Donations in Honor of Giving Tuesday, Surpassing $30M in Total Donations for 2021: https://mms.businesswire.com/media/20191107005201/en/755047/5/Chewy_Logo_Approved.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1lqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--08e9487a1054773dba6bdb2e482bc64f786a2b1c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Chewy_Logo_Approved.jpg?locale=us)
Chewy Matches Customer Donations in Honor of Giving Tuesday, Surpassing $30M in Total Donations for 2021
Chewy, Inc. (“Chewy”) (NYSE: CHWY), a leading online destination for pet parents and partners, announced today a new campaign to support shelters and rescues across the country in partnership with
![Starbucks EMEA Transforms Technology Management and Maximizes Customer Satisfaction with NCR Partnership](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Starbucks EMEA Transforms Technology Management and Maximizes Customer Satisfaction with NCR Partnership
For Starbucks Europe, Middle East and Africa (EMEA), maximizing customer satisfaction and keeping all aspects of a Starbucks café running smoothly is the top priority. Starbucks EMEA, with stores
![Cryptocurrencies With The Greatest Increase In Value And Popularity In 2021](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Cryptocurrencies With The Greatest Increase In Value And Popularity In 2021
New research reveals the cryptocurrencies with the greatest increase in popularity and value in 2021, with one $10 investment a year ago worth over $200,000 today.
Get The Full Ray Dalio
![Pitney Bowes Survey: More than Half of U.S. Has Started Holiday Shopping; Increased Gift Card Spending Will Extend Holiday Shipping into January](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Pitney Bowes Survey: More than Half of U.S. Has Started Holiday Shopping; Increased Gift Card Spending Will Extend Holiday Shipping into January
Pitney Bowes, a global shipping and mailing company that provides technology, logistics, and financial services, today released new findings from its weekly BOXpoll® consumer survey days before
![These Four States Could Send Coronavirus Stimulus Checks in December: https://www.valuewalk.com/wp-content/uploads/2017/02/Singleton-1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNS83VlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--77b67e204023c515660ce62313a44c5358953c0e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Singleton-1.jpg?locale=us)
These Four States Could Send Coronavirus Stimulus Checks in December
We are now approaching the last month of the year 2021, but stimulus payments are still continuing. Though the federal government approved just one stimulus check this year, several states have
![Eaton Demonstrates Long-term Resiliency With Microgrid at Fort Hood, Texas: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24410/Eaton_Color_logo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBY1E9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--ea37be97eddf60340bd98929e037c2269632c8e7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Eaton_Color_logo.png?locale=us)
Eaton Demonstrates Long-term Resiliency With Microgrid at Fort Hood, Texas
Power management company Eaton, in partnership with the U.S. Army Engineer Research and Development Center (ERDC), Construction Engineering Research Laboratory (CERL), and the Department of Public
![Elys Game Technology Reports Record Year-to-Date Betting Handle of $626.9 Million, an Increase of 77% Year-Over-Year, for the 2021 Third Quarter: https://mms.businesswire.com/media/20200617005433/en/779190/5/NewGiocoGroup-logo-Png-Black.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNncwUEE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--552e30815c85bd77a83b5641ece87070492a9f09/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NewGiocoGroup-logo-Png-Black.jpg?locale=us)
Elys Game Technology Reports Record Year-to-Date Betting Handle of $626.9 Million, an Increase of 77% Year-Over-Year, for the 2021 Third Quarter
Elys Game Technology, Corp. (“Elys” or the “Company”) (Nasdaq:ELYS)(NEO:ELYS)(BER:3UW), an interactive gaming and sports betting technology company, today is reporting its financial and operating
![Insperity Announces $2 Special Dividend, Quarterly Dividend of $0.45, and Expands Repurchase Program by 1 Million Shares:](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1dOTWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--18ec7f0ddffe02914646ae92f3e6156744ef57fd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-vertical-transparent.png?locale=us)
Insperity Announces $2 Special Dividend, Quarterly Dividend of $0.45, and Expands Repurchase Program by 1 Million Shares
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today announced that its board of directors has declared a
![MedMen Announces Michael Serruya as Chairman and Interim CEO: https://mms.businesswire.com/media/20191111005149/en/659546/5/Medmen.LogoHorizontalRed.Reg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGU1RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b814bf6c90f88e33b106d8236ea27e17f4e41a84/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/MedmenLogoHorizontalRedReg.jpg?locale=us)
MedMen Announces Michael Serruya as Chairman and Interim CEO
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today announced its Board of Directors has
![IMV Inc. Announces Chief Financial Officer to Retire: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenlNSlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--44b7c2e9ec1d34b6817ce17f4c733565e4a558a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/IMV_Logos_IMV-Logo_BrandStatement.jpg?locale=us)
IMV Inc. Announces Chief Financial Officer to Retire
IMV Inc. (NASDAQ: IMV; TSX: IMV) (“IMV” or “the Company”), a clinical-stage company developing a portfolio of immune-educating cancer therapies based on its novel DPX platform, today announced that
![Inseego Corp. Statement on Infrastructure Investment and Jobs Act: https://mms.businesswire.com/media/20200226005297/en/775865/5/Inseego_logo_high_resolution.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNS9NSlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7e5885a9dc7b514ae7ff5dd902abc2099b8b32ae/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Inseego_logo_high_resolution.jpg?locale=us)
Inseego Corp. Statement on Infrastructure Investment and Jobs Act
Inseego Corp. (Nasdaq: INSG), a leader of 5G and intelligent IoT device-to-cloud solutions for enterprises and consumers, congratulates the U.S. Congress and President Joseph R. Biden for a
![ICON Releases Environmental, Social and Governance Report: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMWRYRVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--91b049194ccf9261ff5ab4a8879b7c494da2dc48/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ICON_Positive_logo_PNG_-28nostrap-29.jpg?locale=us)
ICON Releases Environmental, Social and Governance Report
ICON plc (NASDAQ:ICLR) announced today the release of its 2020 Environmental, Social and Governance (ESG) Report. With the completion of ICON’s acquisition of PRA Health Sciences, the report
![Victory Capital Announces Pricing of $505 Million Incremental Term Loan Facility to Fund WestEnd Advisors Acquisition: https://mms.businesswire.com/media/20200331005113/en/460034/5/VC_Logo_2c.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTJ4TEE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5a481ab3e0cb47b059d2ea8f83b5bfe2891858cd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/VC_Logo_2c.jpg?locale=us)
Victory Capital Announces Pricing of $505 Million Incremental Term Loan Facility to Fund WestEnd Advisors Acquisition
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today announced that it has successfully completed the syndication of a $505 million Incremental Term Loan
State Street Collateral+ Delivers New Analytics and Optimization Capabilities in Partnership with Cassini Systems
State Street Corporation (NYSE:STT) announced today it has added market leading pre-and post-trade optimization and margin analytics capabilities to its Collateral+ service. In partnership with
![Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzJBRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5cbb888b15fc1babe89717dad3b9d241825019eb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/novocure_main-405x.jpg?locale=us)
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
Novocure (NASDAQ: NVCR) today announced that the final patient has been enrolled in the phase 3 pivotal LUNAR trial evaluating the efficacy of Tumor Treating Fields (TTFields) together with immune
![Real Matters Announces Amendment to Normal Course Issuer Bid: https://mms.businesswire.com/media/20191121005199/en/554103/5/RM_high_res_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2lwRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8924b42f63f36c742f555033e951377117803e21/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/RM_high_res_logo.jpg?locale=us)
Real Matters Announces Amendment to Normal Course Issuer Bid
Real Matters Inc. (“Real Matters” or the “Company”) (TSX: REAL) today announced that the Toronto Stock Exchange (“TSX”) has approved an amendment to the Company’s current Normal Course Issuer Bid
![Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced that the